There has been an ongoing evolution in the treatment of psychosis, schizophrenia, bipolar, and other significant psychiatric morbidities. As therapies have evolved, efficacy in treating positive and negative symptoms has (for the most part) remained quite high, and there has been a concerted push to — as the generations of drugs progress ever-forward — reduce the off-target and unwanted side effects of treatment (which also helps to boost compliance with medication-taking behaviors). Dr Ben Locwin shares his expertise on the future of pharmacologic treatment.
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
A survey of health care providers found a lack of knowledge on idiopathic hypersomnia (IH) among physicians, and that the disorder is often misdiagnosed. We spoke with Richard Bogan, MD, FCCP, FAASM, associate clinical professor at the University of the South Carolina School of Medicine about IH and criteria for diagnosing this sleep disorder.
Data from the CDC on suicide deaths indicate a 5.6% decline in suicide deaths between 2019 and 2020 in the United States. We spoke with Christine Yu Moutier, MD, Chief Medical Officer for the American Foundation for Suicide Prevention (AFSP) about this data.
Hanna Saltzman, MD, speaks to the importance of screening for and addressing mental health in a pediatric rheumatology population and discusses the efforts initiated by CARRA workgroups in this direction. A patient with childhood SLE also provides her perspective.
The unprecedented numbers of patients on mechanical ventilation underscore the severity of the coronavirus on public health. Elderly patients, especially those with Parkinson disease, often bear the brunt of the pandemic due to pre-existing pulmonary disease and/or anatomical disposition.
After decades of limited research and legal roadblocks to medical and recreational use, psychedelic drugs are rapidly remerging as treatments of interest in psychiatry. We interviewed two experts in the field.
Even before the COVID-19 pandemic began, concerning mental health trends and major treatment gaps were noted among adolescents. We spoke with Cécile Rousseau, MD, researcher, psychiatrist, and professor in the division of social and transcultural psychiatry at McGill University in Montreal, Canada about the impact of the COVID-19 pandemic on adolescent mental health.
The COVID-19 pandemic led to an exacerbation of pre-existing hardships and disparities in many vulnerable populations, including individuals affected by intimate partner violence. We interviewed experts in the field to learn more about this issue and how clinicians may best assist affected individuals.
With teens relying heavily on their friends and social connections for emotional support, the restrictions imposed to contain COVID-19 are especially hard on them. The C.S. Mott Children’s Hospital National Poll on Children’s Health asked a national sample of parents about the emotional impact pandemic restrictions have had on their teens aged 13 to 18.
For the 12-month period ending in May 2020, the CDC reported 81,000 drug overdose deaths — the most ever recorded in a 12-month period in the United States. We interviewed Danielle F. Haley, MPH, PhD, assistant professor in the department of community health sciences at the Boston University School of Public Health about COVID-19 and the rates of substance abuse and overdose cases.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
Sandhya Prashad, MD discusses how leveraging teletherapy has helped providers and patients troubleshoot common concerns around social distancing and has gotten many first-time patients in the “virtual” door.
To learn more about the multifaceted effects of the COVID-19 pandemic on people living with HIV and how clinicians can best support these patients, we interviewed experts who have co-authored recently published papers pertaining to this topic.
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
We spoke to Carl V Hill, PhD, MPH, chief diversity, equity and inclusion officer of the Alzheimer’s Association about the results of the Alzheimer’s Association report, 2021 Alzheimer’s Disease Facts and Figures.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
The pandemic poses unprecedented challenges to the grieving process, setting the stage for more complex and prolonged reactions in those who have unfortunately lost loved ones. M. Katherine Shear, MD, Marion E. Kenworthy Professor of Psychiatry, Columbia University School of Social Work, Columbia University College of Physicians and Surgeons, New York, NY, and Director of the Center for Complicated Grief shares her insight into this subject.
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.